Oct 3, 2025 | News
The U.S. government, through the President’s Emergency Plan for AIDS Relief (PEPFAR), has announced a groundbreaking commitment to expand access to lenacapavir for pre-exposure prophylaxis (PrEP). This long-acting twice-yearly injectable for HIV prevention will be...
Oct 2, 2025 | News
Yesterday marked ACRN’s first time attending the SACRA South Africa SACRA Conference, an important moment as we joined Africa’s clinical research community to connect, learn, and expand partnerships. Our team – Romina Mariano (Chief of Staff), Wilfred Gurupira...
Oct 2, 2025 | News
At the current Community Engagement Network Forum 2025 in Cape Town, our Community Engagement Officer, Takura mangwiro presented how Mutala, ACRN’s primary clinical trial site, is applying insights from the Zimbabwe Engage Study to strengthen participant...
Oct 2, 2025 | News
During the recent Zimbabwe Annual Scientific Conference (ZASCO), hosted with support from the Zimbabwe National Quality Assurance Program (ZINQAP), Dr Alltalents Tutsirayi Murahwa, PhD, our Laboratory Director and Head of Research, shared the journey of ACRN’s...
Sep 29, 2025 | News
This year’s DPHARM: Disruptive Innovations to Modernize Clinical Trials conference offered a front-row seat to how the clinical research industry is evolving. It was an invaluable opportunity to see not only the exciting innovations but also the challenges that...
Sep 29, 2025 | News
ACRN was honored to participate in this year’s National Association of Physicians of Zimbabwe (NAPAZ) meeting. Although the team had initially hoped to attend the ESACOP gathering, NAPAZ’s role as a key member of ESACOP provided a valuable opportunity to engage...